Title:
NOVEL ANTI-LAG3 ANTIBODIES
Document Type and Number:
WIPO Patent Application WO/2023/072294
Kind Code:
A1
Abstract:
Provided are anti-LAG3 antibodies or antigen-binding fragments thereof, isolated polynucleotides encoding the same, pharmaceutical compositions comprising the same and the uses thereof.
More Like This:
Inventors:
NIU XIAOFENG (CN)
ZHAO JINFENG (CN)
XING ROUMEI (CN)
WU ZHIHAO (CN)
GAO RUI (CN)
QIU YANGSHENG (CN)
LU HONGTAO (CN)
ZHAO JINFENG (CN)
XING ROUMEI (CN)
WU ZHIHAO (CN)
GAO RUI (CN)
QIU YANGSHENG (CN)
LU HONGTAO (CN)
Application Number:
PCT/CN2022/128858
Publication Date:
May 04, 2023
Filing Date:
November 01, 2022
Export Citation:
Assignee:
ELPISCIENCE SUZHOU BIOPHARMA LTD (CN)
ELPISCIENCE BIOPHARMA LTD (CN)
ELPISCIENCE BIOPHARMA LTD (CN)
International Classes:
C07K16/28; A61K39/395; A61P35/00; A61P37/00; G01N33/74
Domestic Patent References:
| WO2015116539A1 | 2015-08-06 | |||
| WO2018201096A1 | 2018-11-01 | |||
| WO2016028672A1 | 2016-02-25 | |||
| WO2017106129A1 | 2017-06-22 | |||
| WO2019129137A1 | 2019-07-04 | |||
| WO2019242619A1 | 2019-12-26 |
Foreign References:
| US20150259420A1 | 2015-09-17 |
Other References:
OHMURA HIROFUMI; YAMAGUCHI KYOKO; HANAMURA FUMIYASU; ITO MAMORU; MAKIYAMA AKITAKA; UCHINO KEITA; SHIMOKAWA HOZUMI; TAMURA SHINGO; : "OX40 and LAG3 are associated with better prognosis in advanced gastric cancer patients treated with anti-programmed death-1 antibody", BRITISH JOURNAL OF CANCER, vol. 122, no. 10, 23 March 2020 (2020-03-23), London, pages 1507 - 1517, XP037113327, ISSN: 0007-0920, DOI: 10.1038/s41416-020-0810-1
Attorney, Agent or Firm:
JUN HE LAW OFFICES (CN)
Download PDF: